Literature DB >> 31467104

Whole-Genome Sequences of 35 Incompatibility Group I1 Plasmid-Carrying Salmonella enterica Isolates from Food Animal and Clinical Sources.

Nesreen H Aljahdali1,2, Pravin R Kaldhone1, Steven L Foley1, Bijay K Khajanchi3.   

Abstract

We sequenced 35 Salmonella enterica isolates carrying incompatibility group I1 (IncI1) plasmids from different serotypes to study their genotypic characteristics. The isolates originated from food animals (n = 32) and human patients (n = 3). All isolates carried IncI1 plasmids, and many had additional plasmids detected along with virulence and antimicrobial resistance genes.
Copyright © 2019 Aljahdali et al.

Entities:  

Year:  2019        PMID: 31467104      PMCID: PMC6715874          DOI: 10.1128/MRA.00831-19

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Bacterial foodborne pathogens such as Salmonella enterica contribute to significant morbidity and mortality worldwide (1). Patients with more severe manifestations of illness often require antimicrobial treatment for resolution of disease (2). Unfortunately, several Salmonella strains are resistant to antimicrobial therapy, and often, this resistance is encoded on plasmids (3). Several plasmid types, including members of the incompatibility group I1 (IncI1), have been implicated in carrying antimicrobial resistance genes (4). Additionally, IncI1 plasmids have been reported to carry genes that may increase the virulence of strains where they reside (4). The aim of this study was to assess the antimicrobial resistance and virulence gene content of IncI1-positive Salmonella. We sequenced 35 Salmonella enterica isolates originating from cattle (n = 12, 34%), swine (n = 4, 11%), turkey (n = 6, 17%), chicken (n = 6, 17%), a chicken farm environment (n = 4, 11%), and human patients (n = 3, 9%). These isolates were collected from different locations in the United States during the period from 1999 to 2009. Isolates selected belong to Salmonella enterica serovars Heidelberg (n = 12, 34%), Typhimurium (n = 10, 29%), Newport (n = 6, 17%), Kentucky (n = 3, 9%), Anatum (n = 1, 3%), Dublin (n = 1, 3%), Cerro (n = 1, 3%), and Montevideo (n = 1, 3%). Isolation approaches and phenotypic characterization of the isolates were described previously (5). We sequenced 35 Salmonella enterica isolates identified as carrying IncI1 plasmids using PCR-based plasmid replicon typing in our previous study (6). Each of the 35 isolates was stored at −80°C in brain heart infusion broth (Remel, Lenexa, KS) containing 20% glycerol, and prior to sequencing, isolates were subcultured on blood agar plates (tryptic soy agar with 5% sheep’s blood; Remel). All plates were incubated at 35°C for 24 hours. Overnight bacterial growth from individual isolates was scraped from the plate with a 1-μl inoculating loop and added to 180 μl animal tissue lysis (ATL) buffer (Qiagen, Valencia, CA, USA). Next, bacterial genomic DNA was extracted using a DNeasy blood and tissue kit (Qiagen). The quality and quantity of the DNA were examined using a NanoDrop instrument (Thermo Fisher Scientific, Grand Island, NY, USA) and a Qubit broad range (BR) assay kit (Thermo Fisher Scientific). DNA libraries were generated using 1 ng of DNA from each sample using the Nextera XT DNA library preparation kit (Illumina, San Diego, CA) and were multiplexed using combinations of two indexes of the Nextera XT index kit (Illumina). Isolates were sequenced in two batches with a maximum of 19 isolates per run. DNA sample libraries were diluted, denatured, and loaded onto the Illumina MiSeq instrument, and sequencing was performed using the v2 500-cycle kits. The two runs were monitored using a sequence analysis viewer with an emphasis on appropriate cluster densities of 1,193,000/mm2 with the final quality score (>Q30 score of 80.41) and 1,326,000/mm2 with the final quality score (>Q30 score of 80.66). FASTQ files were demultiplexed with MiSeq software, and the reads for each isolate were assembled using CLC Genomics Workbench ver. 9.0 (Qiagen, Redwood City, CA). Sequences were annotated initially using the Pathosystems Resource Integration Center (PATRIC) software version 3.5.36 (7). Subsequently, sequences were submitted to NCBI for final annotation through the Prokaryotic Genome Annotation Pipeline (PGAP) to annotate the draft genomes of these strains (8). The numbers of contigs, assembly sizes, coding sequences (CDS), and GC contents were annotated by PATRIC as shown in Table 1. The final annotations performed by the PGAP are available in NCBI under the accession numbers shown in Table 1.
TABLE 1

Whole-genome sequencing analyses of 35 Salmonella enterica isolates from food animal and clinical sources

IsolateSerotypeSourceYr of isolationNo. of sequence readsN50 (bp)No. of contigsGenome length (bp)No. of CDSG+C content (%)Accession no.
67NewportCattle20025,019,56125,4244854,486,8204,67852.15VCBN00000000
74NewportCattle20024,989,25225,0854204,328,1884,48152.22VCBO00000000
76NewportChicken20014,926,52332,3583434,349,5374,47552.15VCBP00000000
89NewportSwine20014,977,55426,4434074,620,5584,75552.18VCIK00000000
93NewportSwine20025,027,14332,1873204,403,7174,58652.10VCIL00000000
100NewportTurkey20014,837,17442,1172944,355,3014,41952.15VCIM00000000
111HeidelbergCattle20015,182,38329,0763634,895,5605,07651.95VCIN00000000
114HeidelbergCattle20025,138,95022,6185174,917,8065,12352.00VCIO00000000
115HeidelbergCattle20025,191,94345,5142634,657,3424,80351.96VCIP00000000
116HeidelbergCattle20025,248,27230,4023854,895,1765,11551.82VCIQ00000000
159HeidelbergTurkey20025,111,40331,4953104,737,3254,92451.78VCIR00000000
470TyphimuriumSwine19998,612,1347,8284254,407,6584,61052.42VCSK00000000
471TyphimuriumSwine19995,001,94720,2904904,718,1374,88252.32VCIT00000000
482TyphimuriumTurkey19994,960,48024,2164174,670,0434,76352.22VCIU00000000
695HeidelbergTurkey20005,071,07128,2313804,907,9615,02651.96VCIV00000000
706HeidelbergTurkey20004,897,84625,1014054,522,0774,64952.13VDBX00000000
715HeidelbergTurkey20004,848,41236,2302794,613,5974,71452.15VCPT00000000
121HeidelbergCattle20024,846,03736,6113794,843,6825,00652.23VCSL00000000
N134TyphimuriumChicken farmUnknown5,086,47892,5401304,508,6604,68352.00VCQG00000000
N53TyphimuriumChickenUnknown5,049,70119,6225774,912,1525,09152.23VCQH00000000
849DublinCattle20055,047,82942,8992364,599,9154,80251.99VCPU00000000
855TyphimuriumCattle20065,014,62549,9062264,499,8754,63252.05VCPV00000000
856CerroCattle20064,568,47821,6264374,470,1374,52152.42VCPW00000000
N865KentuckyChicken20084,879,80223,2605034,523,9524,61552.08VCQJ00000000
880MontevideoCattle20064,694,16843,5142824,251,5454,35052.34VCIS00000000
891AnatumCattle20064,741,58028,6373004,601,2554,65752.18VCPY00000000
990HeidelbergHuman20085,098,17033,3953034,892,0635,06151.85VCQK00000000
1000HeidelbergHuman20095,087,59923,7134534,773,9544,96251.87VCPZ00000000
1163HeidelbergHuman20074,950,68149,6563444,678,1684,85452.01VCQB00000000
N822KentuckyChicken farm20084,891,56823,5035114,533,1594,69152.12VCQI00000000
N860KentuckyChicken20084,880,24727,6984174,486,1604,58952.02VDBM00000000
N136TyphimuriumChicken farmUnknown5,082,91941,4412754,700,8864,82052.02VCQC00000000
N74TyphimuriumChickenUnknown5,099,54535,1083264,587,2574,78051.88VCQD00000000
N82TyphimuriumChicken farmUnknown5,056,64422,9864974,740,9144,92852.12VCQE00000000
N97TyphimuriumChickenUnknown5,054,42836,1022794,729,7174,85952.04VCQF00000000
Whole-genome sequencing analyses of 35 Salmonella enterica isolates from food animal and clinical sources Sequence data from each of the isolates were further analyzed using the PlasmidFinder (9) and ResFinder (10) tools to predict the presence of plasmids and antimicrobial resistance genes, respectively. PlasmidFinder analyses confirmed that all isolates contained IncI1 plasmids, many along with other plasmid replicon types, including IncA/C (n = 14, 40%), IncHI2 (n = 8, 23%), IncColpVC (n = 9, 26%), IncX1 (n = 7, 20%), and IncFIB (n = 6, 17%). ResFinder analyses were performed by selecting acquired antimicrobial resistance genes with default parameter settings. Multiple antimicrobial resistance genes, including tet(A) in 51% (n = 18) of the strains, followed by blaCMY-2 (n = 17, 49%), aph(3ʺ)-Ib (n = 16, 46%), sul2 (n = 14, 40%), fosA7 (n = 12, 34%), aadA1 (n = 12, 34%), floR (n = 10, 29%), sul1 (n = 9, 26%), tet(B) (n = 9, 26%), blaTEM-1B (n = 8, 23%), dfrA1 (n = 4, 11%), blaTEM-1A (n = 1, 3%), sul3 (n = 1, 3%), dfrA2 (n = 1, 3%), cml (n = 1, 3%), and cmlA1 (n = 1, 3%), were most commonly detected among the sequences. Default parameters were used for all bioinformatic software tools unless otherwise specified.

Data availability.

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession numbers listed in Table 1, and the SRA submission of the FASTQ files has been recorded under the accession number PRJNA543125.
  4 in total

Review 1.  Incompatibility Group I1 (IncI1) Plasmids: Their Genetics, Biology, and Public Health Relevance.

Authors:  Steven L Foley; Pravin R Kaldhone; Steven C Ricke; Jing Han
Journal:  Microbiol Mol Biol Rev       Date:  2021-04-28       Impact factor: 11.056

2.  Whole-Genome Sequences of 66 Incompatibility Group FIB Plasmid-Carrying Salmonella enterica Serovar Typhimurium Isolates from Food Animal Sources.

Authors:  Nesreen H Aljahdali; Steven L Foley; Jing Han; Yasser M Sanad; Rajesh Nayak; Bijay K Khajanchi
Journal:  Microbiol Resour Announc       Date:  2020-01-30

Review 3.  The Dynamics of the Antimicrobial Resistance Mobilome of Salmonella enterica and Related Enteric Bacteria.

Authors:  Suad Algarni; Steven C Ricke; Steven L Foley; Jing Han
Journal:  Front Microbiol       Date:  2022-03-31       Impact factor: 5.640

4.  Genotypic and Phenotypic Characterization of Incompatibility Group FIB Positive Salmonella enterica Serovar Typhimurium Isolates from Food Animal Sources.

Authors:  Nesreen H Aljahdali; Bijay K Khajanchi; Kennedi Weston; Joanna Deck; Justin Cox; Ruby Singh; Jeffrey Gilbert; Yasser M Sanad; Jing Han; Rajesh Nayak; Steven L Foley
Journal:  Genes (Basel)       Date:  2020-11-04       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.